Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report)’s share price was up 0.5% during trading on Thursday . The stock traded as high as $48.77 and last traded at $48.77. Approximately 362 shares traded hands during trading, a decline of 57% from the average daily volume of 850 shares. The stock had previously closed at $48.51.
Hikma Pharmaceuticals Stock Performance
The company’s 50-day simple moving average is $49.49 and its 200 day simple moving average is $50.08.
About Hikma Pharmaceuticals
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.
Recommended Stories
- Five stocks we like better than Hikma Pharmaceuticals
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Micron Stock Under $100: Seize the AI-Driven Upside
- What is a Stock Market Index and How Do You Use Them?
- AI’s Next Big Winners: 3 Small-Cap Stocks to Watch in 2025
- When to Sell a Stock for Profit or Loss
- SolarEdge Stock Climbs Back: Goldman Sachs Sees 40% Upside
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
